Excitingly, a synthetic p19Arf peptide (amino acids 26 to 44) was sufficient to sequester Foxm1b in nucleoli [37], effectively inhibiting the primary and metastatic growth of Foxm1b transgenic; Arf−/− liver cancer cells without affecting normal hepatocytes [44,60]. This evidence concerns the gene FOXM1 and liver cancer.